HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Silk Selected Research

SRI-5 (SRI 5)

1/2018Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Silk Research Topics

Disease

2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023 - 05/2022
2Inflammation (Inflammations)
05/2022 - 01/2018
1Herpes Zoster
01/2023
1Infections
01/2023
1Arthralgia (Joint Pain)
05/2022
1Necrosis
05/2022
1Central Nervous System Diseases (CNS Diseases)
01/2018

Drug/Important Bio-Agent (IBA)

2baricitinibIBA
01/2023 - 05/2022
2Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2018
1Janus Kinase InhibitorsIBA
01/2023
1Interleukin-6 (Interleukin 6)IBA
05/2022
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
05/2022
1DNA (Deoxyribonucleic Acid)IBA
05/2022
1LigandsIBA
05/2022
1ChemokinesIBA
05/2022
1Janus KinasesIBA
05/2022
1SRI-5 (SRI 5)IBA
01/2018

Therapy/Procedure

2Therapeutics
01/2023 - 05/2022